NCT04296695 - Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

December 13, 2022

Study Completion Date

December 31, 2023

Conditions

HIV-1-infection

Interventions

DRUG

B/F/TAF

randomized, multicentered, open-lable RCT, one arm with B/F/TAF and one arm with TDF/3TC/EFV

DRUG

TDF/3TC/EFV

Trial Locations (3)

The Second Hospital of Nanjing, Najing

Tianjin Second People's Hospital, Tianjin

The Guangxi Zhuang Autonomous Region Longtan Hospital, Liuzhou